Results 281 to 290 of about 78,922 (310)
Some of the next articles are maybe not open access.
Bacterial Resistance to Carbapenems
1995The carbapenems have the broadest spectra of all beta-lactams but resistance still occurs, caused by target modification, impermeability or beta-lactamase production. Target modification or replacement is important in methicillin-resistant staphylococci, E. faecium and some pneumococci.
openaire +2 more sources
Options for treating carbapenem-resistant Enterobacteriaceae
Current Opinion in Infectious Diseases, 2014To address the therapeutic management of carbapenem-resistant Enterobacteriaceae on the basis of literature of the last 12 months.Retrospective and prospective (nonrandomized noncontrolled) studies provide data regarding the management of infections due to carbapenem-resistant Enterobacteriaceae.
Petros I, Rafailidis, Matthew E, Falagas
openaire +2 more sources
[Carbapenem resistance in enterobacteria].
Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, 2009Carbapenems are the drugs of choice in the treatment of serious infections caused by multiresistant Gram-negative bacteria. Clinically and epidemiologically, resistance to these beta-lactams poses the highest risk. In enterobacteria, two common mechanisms can cause the resistance to carbapenems: (1) hydrolysis of carbapenems by beta-lactamases and (2 ...
J, Hrabák, E, Chudácková
openaire +1 more source
The Rise of Carbapenem-Resistant Acinetobacter baumannii
Current Pharmaceutical Design, 2012Acinetobacter spp. are Gram-negative bacteria that have become one of the most difficult pathogens to treat. The species A. baumannii, largely unknown 30 years ago, has risen to prominence particularly because of its ability to cause infections in immunocompromised patients.
Evans, Benjamin A. +2 more
openaire +3 more sources
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward
Ca-A Cancer Journal for Clinicians, 2021Amila K Nanayakkara, Kevin Outterson
exaly
Screening for carbapenem-resistant bacteria
The Lancet Infectious Diseases, 2005James S, Soothill, Paul E, Lock
openaire +2 more sources
Colistin resistance in Carbapenem-resistant Klebsiella pneumoniae strains.
2016Objective: Because of the increase in the infections caused by carbapenem-resistant Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae; nowadays colistin is used more frequently. In this study, the firstly detected colistin resistance in carbapenem-resistant KPC-producing K. pneumoniae strains were evaluated.
Kalem F. +6 more
openaire +2 more sources
Artemisinin Resistance in Thailand; Carbapenem Resistance Spreading
Microbe Magazine, 2011Artemisinin-resistant malaria, seen along the border between Thailand and Cambodia, is “very worrying” and, if it spreads, could lead to a “disaster,” says Arjen Dondorp of the Mahidol-Oxford Research Unit in Bangkok, Thailand. Similarly, widespread resistance to carbapenems among gram-negative bacterial pathogens is a “hydra-headed threat,” says David
openaire +1 more source